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Abstract
DNA cruciforms play an important role in the regulation of natural processes involving DNA. These structures are
formed by inverted repeats, and their stability is enhanced by DNA supercoiling. Cruciform structures are
fundamentally important for a wide range of biological processes, including replication, regulation of gene
expression, nucleosome structure and recombination. They also have been implicated in the evolution and
development of diseases including cancer, Werner’s syndrome and others.
Cruciform structures are targets for many architectural and regulatory proteins, such as histones H1 and H5,
topoisomerase IIb, HMG proteins, HU, p53, the proto-oncogene protein DEK and others. A number of DNA-binding
proteins, such as the HMGB-box family members, Rad54, BRCA1 protein, as well as PARP-1 polymerase, possess
weak sequence specific DNA binding yet bind preferentially to cruciform structures. Some of these proteins are, in
fact, capable of inducing the formation of cruciform structures upon DNA binding. In this article, we review the
protein families that are involved in interacting with and regulating cruciform structures, including (a) the junction-
resolving enzymes, (b) DNA repair proteins and transcription factors, (c) proteins involved in replication and (d)
chromatin-associated proteins. The prevalence of cruciform structures and their roles in protein interactions,
epigenetic regulation and the maintenance of cell homeostasis are also discussed.
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Review
Genome sequencing projects have inundated us with
information regarding the genetic basis of life. While
this wealth of information provides a foundation for our
understanding of biology, it has become clear that the
DNA code alone does not hold all the answers. Epige-
netic modifications and higher order DNA structures
beyond the double helix also contribute to basic biologi-
cal processes and maintaining cellular stability. Local
alternative DNA structures are known to exist in all life
forms [1]. The negative supercoiling of DNA can induce
local nucleotide sequence-dependent conformational
changes that give rise to cruciforms, left-handed DNA,
triplexes and quadruplexes [2-4]. The formation of cru-
ciforms is strongly dependent on base sequence and
requires perfect or imperfect inverted repeats of 6 or
more nucleotides in the DNA sequence [5,6]. Over-
representation of inverted repeats, which occurs nonran-
domly in the DNA of all organisms, has been noted in
the vicinity of breakpoint junctions, promoter regions,
and at sites of replication initiation [3,7,8]. Cruciform
structures may affect the degree of DNA supercoiling,
the positioning of nucleosomes in vivo [9], and the for-
mation of other secondary structures of DNA. Cruci-
forms contain a number of structural elements that
serve as direct protein-DNA targets. Numerous proteins
have been shown to interact with cruciforms, recogniz-
ing features such as DNA crossovers, four-way junc-
tions, and curved or bent DNA. Structural transitions in
chromatin occur concomitantly with DNA replication or
transcription and in processes that involve a local
separation of DNA strands. Such transitions are believed
to facilitate the formation of alternative DNA structures
[10,11]. Transient supercoils are formed in the eukaryo-
tic genome during DNA replication and transcription,
and these often involve protein binding [12]. Indeed,
active chromatin remodeling is a typical feature for
many promoters and is essential for gene transcription
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impact on gene expression [14]. Using microarrays cov-
ering the E. coli genome, it was recently shown that
expression of 7% of genes was rapidly and significantly
affected by a loss of chromosomal supercoiling [15].
Several complexes that involve extensive DNA-protein
interactions, whereby the DNA wraps around the pro-
tein, can only occur under conditions of negative DNA
supercoiling [10]. Other proteins are reported to interact
with the supercoiled DNA (scDNA) at crossing points
or on longer segments of the interwound supercoil
[16,17]. Interestingly, the eukaryotic genome has been
shown to contain a percentage of unconstrained super-
coils, part of which can be attributed to transcriptional
regulation [3]. The spontaneous generation of DNA
supercoiling is also a requirement for genome organiza-
tion [18]. Transient supercoils are formed both in front
of and behind replication forks as superhelical stress is
distributed throughout the entire replicating DNA mole-
cule [19]. A number of additional processes may operate
to create transient and localized superhelical stresses in
eukaryotic DNA.
The recognition of cruciform DNA seems to be criti-
cal not only for the stability of the genome, but also for
numerous, basic biological processes. As such, it is not
surprising that many proteins have been shown to exhi-
bit cruciform structure-specific binding properties. In
this review, we focus on these proteins, many of which
are involved in chromatin organization, transcription,
replication, DNA repair, and other processes. To orga-
nize our review, we have divided cruciform binding pro-
teins into four groups (see Table 1) according to their
primary functions: (a) junction-resolving enzymes, (b)
transcription factors and DNA repair proteins, (c) repli-
cation machinery, and (d) chromatin-associated proteins.
For each group, we describe in detail recent examples of
research findings. Lastly, we review how dysregulation
of cruciform binding proteins is associated with the
pathology of certain diseases found in humans.
Formation and presence of cruciform structures in the
genome
Cruciform structures are important regulators of biolo-
gical processes [3,5]. Both stem-loops and cruciforms
are capable of forming from inverted repeats. Cruciform
structures consist of a branch point, a stem and a loop,
where the size of the loop is dependent on the length of
the gap between inverted repeats (Figure 1). Direct
inverted repeats lead to formation of a cruciform with a
minimal single-stranded loop. The formation of cruci-
forms from indirect inverted repeats containing gaps is
dependent not only on the length of the gap, but also
on the sequence in the gap. In general, the AT-rich gap
sequences increase the probability of cruciform
formation. It is also possible that the gap sequence can
form an alternative DNA structure. The formation of
DNA cruciforms has a strong influence on DNA geome-
try whereupon sequences that are normally distal from
one another can be brought into close proximity
[20,21]. The structure of cruciforms has been studied by
a t o m i cf o r c em i c r o s c o p y[ 2 2 - 2 4 ] .T h e s es t u d i e sh a v e
identified two distinct classes of cruciforms. One class
of cruciforms, denoted as unfolded, have a square planar
conformation characterized by a 4-fold symmetry in
which adjacent arms are nearly perpendicular to one
another. The second class comprises a folded (or
stacked) conformation where the adjacent arms form an
acute angle with the main DNA strands (Figure 2). Two
of the three structural motifs inherent to cruciforms, the
branch point and stem, are also found in Holliday junc-
tions. Holliday junctions are formed during recombina-
tion, double-strand break repair, and fork reversal
during replication. Resolving Holliday junctions is a cri-
tical process for maintaining genomic stability [25,26].
These junctions are resolved by a class of structure-spe-
cific nucleases: the junction-resolving enzymes.
Cruciforms are not thermodynamically stable in naked
linear DNA due to branch migration [27]. Cruciform
structure formation in vivo has been shown in both pro-
karyotes and eukaryotes using several methodological
approaches. The presence of the cruciform structure
was first described in circular plasmid DNA where the
negative superhelix density can stabilize cruciform for-
mation. Plasmids with native superhelical density usually
contain cruciform structures in vitro and in vivo [28].
For example, higher order structure in the pT181 plas-
mid was shown to exist in vivo using bromoacetalde-
hyde treatment [29]. Deletion of the sequence which
forms this structure at the ori site leads either to a
reduction or failure in replication [30]. Similarly, dele-
tion of the cruciform binding domain in 14-3-3 proteins
results in reduced origin binding which affects the initia-
tion of DNA replication in budding yeast [31]. Monoclo-
nal antibodies against cruciform structures have also
been used successfully to isolate cruciform-containing
segments of genomic DNA. Furthermore, these
sequences were able to replicate autonomously when
transfected into HeLa cells [32]. Stabilization of the cru-
ciform structures by monoclonal antibodies 2D3 and
4B4, with anti-cruciform DNA specificity, resulted in a
2- to 6-fold enhancement of replication in vivo [33]. 14-
3-3 sigma was found to associate in vivo with the mon-
key origins of DNA replication ors8 and ors12 in a cell
cycle-dependent manner, as assayed by a chromatin
immunoprecipitation (ChIP) assay that involved formal-
dehyde cross-linking, followed by immunoprecipitation
with anti-14-3-3 sigma antibody and quantitative PCR
[34]. Similarly, the 14-3-3 protein homologs from
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Page 2 of 16Table 1 Proteins involved in interactions with cruciform structures
Protein Source Reference
Junction-resolving enzymes
Integrase family
RuvC E.coli [133-135]
Cce1 yeast [136]
Ydc2 S.pombe [134]
A22 Coccinia virus [137]
Integrases all [119,138]
Restriction nuclease family
Endonuclease I Phage T7 [139-141]
RecU G+ bacteria [134,142]
Hjc, Hje archea [134,143]
MutH Eukaryotes [25,144]
Other
Endonuclease VII phage T4 [25,145]
RusA E.coli [146]
MSH2 S. cerevisiae [147,148]
Mus81-Eme1 Eukaryotes [42,149-151]
TRF2 H. sapiens [52,152]
XPF, XPG protein families Eukaryotes [56,153,154]
Transcription, Transcription factors and DNA repair
PARP-1 H. sapiens and others [51,63]
BRCA1 H. sapiens and others [49,50,91,93]
P53 H. sapiens and others [69,73,75,76,132,155,156]
Bmh1 S.cerevisiae [35]
14-3-3 H. sapiens, S.cerevisiae [34,110]
Rmi-1 Yeast [157]
Crp-1 S. cerevisiae [158]
HMG protein family all [47,159-161]
Smc S. cerevisiae [118,162]
Hop1 S. cerevisiae [163,164]
ER estrogen receptor mammals [58]
Chromatin-associated proteins
DEK mammals [84,85]
BRCA1 mammals [49,50,91,93]
HMG protein family Eukaryotes [47,159-161]
Rad54 Eukaryotes [48]
Rad51ap Eukaryotes [81]
Topoisomerase I Eukaryotes [101,165]
Replication
S16 E.coli [113]
GF14, homolog of 14-3-3 plants [35]
MLL (leukemia) H. sapiens [125,126]
WRN (Werner syndrome) H. sapiens [129]
AF10 H. sapiens [114]
14-3-3 Eukaryotes [34,110]
DEK mammals [84,85]
DNA-PK Eukaryotes [166]
Vlf-1 Baculovirises [119]
HU E. coli [105,167,168]
Helicases (59, 44, and others) all [55]
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ciform DNA-binding activity and associate in vivo with
ARS307 [35]. Several studies show that transcription is
regulated directly by the presence of cruciform structure
in vivo. Another example includes the ability of the d
(AT)n-d(AT)n insert to spontaneously adopt a cruci-
form state in E. coli, resulting in a block of protein
synthesis [36]. Using site-directed mutational analysis
and P1 nuclease mapping, it was demonstrated that the
formation of a cruciform structure is required for the
repression of enhancer function in transient transfection
assays and that Alu elements may contribute to regula-
tion of the CD8 alpha gene enhancer through the for-
mation of secondary structure that disrupts enhancer
function [37]. Transcriptionally driven negative super-
coiling also mediates cruciform formation in vivo and
enhanced cruciform formation correlates with an eleva-
tion in promoter activity [38]. It was also shown that
the secondary DNA structures of the ATF/CREB ele-
ment play a vital role in protein-DNA interactions and
its cognate transcription factors play a predominant role
in the promoter activity of the RNMTL1 gene [39].
Figure 1 Changes associated with transition from the linear to cruciform state in the p53 target sequence from the p21 promoter. The
promoter sequence contains a 20 bp p53 target sequence with 7 bp long inverted repeat (red), (A) as linear DNA and (B) as an inverted repeat
as a cruciform structure. In the cruciform structure, the p53 target sequence is presented as stems and loops.
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methylase show that these sequences are consistent with
an unusual secondary structure, such as DNA cruciform
or hairpin in vivo [40]. The in vivo effects of cruciform
formation during transcription have been studied in
detail by Krasilnikov et al. [4]. Interestingly hairpin-
capped linear DNA (in which the replication of hairpin-
capped DNA and cruciform formation and resolution
play central roles) was stably maintained for months in
a human cancer cell line as numerous extra-chromoso-
mal episomes [41]. Long palindromes can also induce
DNA breaks after assuming a cruciform structure. Palin-
dromes in S. cerevisiae are resolved, in vivo,b ys t r u c -
ture-specific enzymes. In vivo resolution requires either
the Mus81 endonuclease or, as a substitute, the bacterial
HJ resolvase RusA. These findings provide confirmation
Figure 2 Conformations of a cruciform structure. Conformations of a cruciform can vary from (A) “unfolded” with 4-fold symmetry to (B)
bent, and to (C) “stacked” with 4 chains of DNA in close vicinity. D) Topology of a Holliday junction stabilized by a psoralen cross-linking agent
(PDBID 467D). Here, the junction takes the form of an anti-parallel stacked x-structure.
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eukaryotic chromatin [42]. Taken together, these studies
show that cruciforms have been detected in vivo using a
variety of independent techniques and that they are an
intriguing and integral phenomenon of DNA biology
and biochemistry.
Proteins involved in interactions with cruciform structures
Junction-resolving enzymes
There are a large number of proteins that recognize cru-
ciforms (summarized in Table 1) and, of these, the junc-
tion-resolving enzymes have been studied extensively.
These proteins have been identified in many organisms
from bacteria (and their phages) to yeast, archea and
mammals [43]. The majority of the junction-resolving
enzymes can be divided into one of two superfamilies
[44]. Those in the first class target specific DNA
sequences for enzymatic activity, although they will bind
equally well to junctions of any sequence. This super-
family includes E. coli RuvC, the yeast integrases, Cce1,
Ydc2, and RnaseH. The second group includes the
phage T7, endonuclease RecU, the Hjc and Hje resol-
ving enzymes, the MutH protein family and related
restriction enzymes. The x-ray structures of the junc-
tion-resolving enzymes in complex with 4-way junctions
highlight the flexibility inherent to DNA (Figure 3) [25]
in that these enzymes recognize and distort the junction.
This enables them to carry out such key roles as the
cleavage of allogene DNAs and maintenance of genomic
stability to name but a few. The recognition of non-B-
DNA structure by junction-resolving enzymes has been
the subject of several reviews [25,43,45,46].
Proteins involved in transcription and DNA repair
The maintenance of a cell’s genomic stability is achieved
through several independent mechanisms. Arguably, the
most important of these mechanisms is DNA repair.
Protein binding to damaged DNA and to the local alter-
native DNA structures is therefore a key function of
these processes. The promoter regions of genes are
often characterized by presence of inverted repeats that
are capable of forming cruciforms in vivo.An u m b e ro f
DNA-binding proteins, such as those of the HMGB-box
family [47], Rad54 [48], BRCA1 protein [49,50], as well
as PARP-1 (poly(ADP-ribose) polymerase-1) [51], dis-
play only a weak sequence preference but bind preferen-
tially to cruciform structures. Moreover, some proteins
can induce the formation of cruciform structures upon
DNA binding [51,52]. Among the DNA repair proteins
which bind to cruciforms are the junction-resolving
enzymes Ruv and RuvB [53,54], DNA helicases [55],
XPG protein [56], and multifunctional proteins like
HMG-box proteins [57] BRCA1, 14-3-3 protein family
including homolog’s Bmh1 and Bmh2 from S. cerevisiae,
and GF14 from plants. Footprinting analysis of the
gonadotropin-releasing hormone gene promoter region
indicated the human estrogen receptor (ER) to be
another potential cruciform binding protein. In this
case, extrusion of the cruciform structure allowed the
estrogen response elements motifs to be accessed by the
ER protein [58].
PARP-1 PARP-1 is an abundant, nuclear, zinc-finger
protein present in ~ 1 enzyme per 50 nucleosomes. It
has a high affinity for damaged DNA and becomes cata-
lytically active upon binding to DNA breaks [59]. In the
absence of DNA damage, the presence of PARP-1 leads
to the perturbation of histone-DNA contacts allowing
DNA to be accessible to regulatory factors [60]. PARP-1
activity is also linked to the coordination of chromatin
structure and gene expression in Drosophila [61]. It was
reported that PARP can bind to the DNA hairpins in
heteroduplex DNA and that the auto-modification of
PARP in the presence of NAD+ inhibited its hairpin
binding activity. Atomic force microscopy studies
revealed that, in vitro, PARP protein has a preference
for the promoter region of the PARP gene in superheli-
cal DNA where the dyad symmetry elements form hair-
pins (Figure 4) [62]. PARP-1 recognizes distortions in
the DNA backbone allowing it to bind to three- and
four-way junctions [63]. Kinetic analysis has revealed
that the structural features of non-B form DNA are
important for PARP-1 catalysis activated by undamaged
DNA. The order of PARP-1’s substrate preference has
been shown to be: cruciforms > loops > linear DNA.
These results suggest a link between PARP-1 binding to
cruciforms structures in the genome and its function in
the modulation of chromatin structure in cellular pro-
cesses. Moreover, it was shown that the binding of
PARP-1 to DNA can induce changes in DNA topology
as was demonstrated using plasmid DNA targets [51].
P53 P53 is arguably one of the most intensively studied
tumor suppressor genes. More than 50% of all human
tumors contain p53 mutations and the inactivation of
this gene plays a critical role in the induction of malig-
nant transformation [64]. Sequence-specific DNA bind-
ing is crucial for p53 function. P53 target sequences,
which consist of two copies of the sequence 5’-RRRC(A/
T)(T/A)GYYY-3, often form inverted repeats [65]. It
was reported that p53 binding is temperature sensitive
and dependent on DNA fragment length [66,67]. More-
over, it was demonstrated, in vivo,t h a tp 5 3b i n d i n gt o
its target sequence is highly dependent on the presence
of an inverted repeat at the target site. Preferential bind-
ing of p53 to superhelical DNA has also been described
[68,69]. Non-canonical DNA structures such as mis-
matched duplexes, cruciform structures [70], bent DNA
[71], structurally flexible chromatin DNA [13], hemica-
tenated DNA [72], DNA bulges, three- and four-way
junctions [73], or telomeric t-loops [74] can all be
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between the cruciform-forming targets and an enhance-
ment of p53 DNA binding [75]. Target sequences cap-
able of forming cruciform structures in topologically
constrained DNA bound p53 with a remarkably higher
affinity than did the internally asymmetrical target site
[76]. These results implicate DNA topology as having an
important role in the complex, with possible implica-
tions in modulation of the p53 regulon.
Chromatin-associated proteins
The chromatin-associated proteins cover a broad spec-
trum of the proteins localized in the cell nucleus. They
Figure 3 Crystal structure of the E. coli RuvA tetramer in complex with a Holliday junction (PDBID 1C7Y). A) The Holliday junction is
depressed at the center where it makes close contacts with RuvA. Each of the arms outside of the junction center takes on a standard beta-
DNA conformation B) Rotation of A) by 90°.
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but are also implicated in a range of processes asso-
ciated with DNA function. They fine-tune transcrip-
tional events (DEK, BRCA1) and are involved in both
DNA repair and replication (HMG proteins, Rad51,
Rad51ap, topoisomerases). Another family of enzymes
deemed important in these processes is that of topoi-
somerases. These enzymes occur in all known organisms
and play crucial roles in the remodeling of DNA topol-
ogy. Topoisomerase I binds to Holliday junctions [77],
and topoisomerase II recognizes and cleaves cruciform
structures [78] and interacts with the HMGB1 protein
[57]. These processes are particularly important for
maintaining genomic stability due to their ability to dif-
fuse the stresses that are levied upon a DNA molecule
during transcription, replication and the resolving of
long cruciforms that wouldo t h e r w i s eh i n d e rD N A
chain separation. The Rad54 protein plays an important
role during homologous recombination in eukaryotes
[79]. Yeast and human Rad54 bind specifically to Holli-
day junctions and promote branch migration [80]. The
binding preference for the open conformation of the X-
junction appears to be common for many proteins that
bind to Holliday junctions. Human Rad54 binds prefer-
entially to the open conformation of branched DNA as
opposed to the stacked conformation [48]. Similarly,
RAD51AP1, the RAD51 accessory protein, specifically
stimulates joint molecule formation through the combi-
nation of structure-specific DNA binding and by inter-
acting with RAD51. RAD51AP1 has a particular affinity
for branched-DNA structures that are obligatory inter-
mediates during joint molecule formation [81]. The
recognition of branched structures during homologous
recombination is a critical step in this process.
DEK The human DEK protein is an abundant nuclear
protein of 375 amino acids that occurs in numbers
greater than 1 million copies per nucleus [82]. Its inter-
actions with transcriptional activators and repressors
s u g g e s tt h a tD E Km a yh a v ear o l ei nt h ef o r m a t i o no f
transcription complexes at promoter and enhancer sites
[reviewed in [83]]. The binding of DEK to DNA is not
sequence specific and DEK has a clear preference for
supercoiled and four-way junctions [84]. Work with iso-
lated and recombinant DEK has shown that it has
intrinsic DNA-binding activity with a preference for
four-way junction and superhelical DNA over linear
DNA and introduces positive supercoils into relaxed cir-
cular DNA [83,85]. DEK has two DNA-binding
domains. The first domain is centrally located and har-
bors a conserved sequence element, the SAF (scaffold
attachment factor). The second DNA-binding domain is
located at the C-terminus of DEK which is also post-
translationally modified by phosphorylation. In fact, the
DNA-binding properties of DEK are clearly influenced
Figure 4 AFM and SFM images of proteins binding to a cruciform structure. A) AFM images of PARP-1 binding to supercoiled pUC8F14
plasmid DNA containing a 106 bp inverted repeat. PARP-1 binds to the end of the hairpin arm (white arrow). Images show 300 × 300 nm
2
surface areas (reprinted with permission from [51]. B) The interaction between p53CD and supercoiled DNA gives rise to cruciform structures.
Shown is an SFM image of complex formed between p53CD and sc pXG(AT)34 plasmid DNA at a molar ratio of 2.5; the complexes were
mounted in the presence of 10 mM MgAc2. The scale bars represent 200 nm (reprinted with permission from [132].
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weaker affinity to DNA than does unmodified DEK and
induces the formation of DEK multimers [86,87]. DEK’s
monomeric SAF box (residues 137-187) does not appear
to interact with DNA in solution. However, when many
SAF boxes are brought into close proximity, it coopera-
tivity drives DNA binding. A DEK construct spanning
amino acids 87-187 binds to DNA much like the intact
DEK preferring four-way DNA junctions over linear
DNA. This fragment forms large aggregates in the pre-
sence of DNA and is also able to introduce supercoils
into relaxed circular DNA. Interestingly, the 87-187
amino acid peptide induces negative DNA supercoils
[88].
BRCA1 BRCA1 is a multifunctional tumor suppressor
protein having roles in cell cycle progression, transcrip-
tion, DNA repair and chromatin remodeling. Mutations
to the BRCA1 gene are associated with a significant
increase in the risk of breast cancer. The function of
BRCA1 likely involves interactions with both DNA and
an array of proteins. BRCA1 associates directly with
RAD51 and both proteins co-localize to discrete sub-
nuclear foci that redistribute to sites of DNA damage
under genotoxic stress [89]. BRCA1 also co-localizes
with phosphorylated H2AX (gH2AX) in response to
double strand breaks [90].
The central region of human BRCA1 binds strongly to
negatively supercoiled plasmid DNA with native super-
helical density [50] and binds with high affinity to cruci-
form DNA [91]. The BRCA1 cruciform DNA complex
must dissociate to allow the nuclease complex to work
in DNA recombinational repair of double stranded
breaks. BRCA1 also acts as a scaffold for assembly of
the Rad51 ATPase which is responsible for homologous
recombination in somatic cells. The full-length BRCA1
protein binds strongly to supercoiled plasmid DNA and
to junction DNA. The difference in affinity was on the
order of 6- to 7-fold between linear and junction DNA
in reactions containing physiological levels of magne-
sium [92]. BRCA1 230-534 binds with a higher affinity
to four-way junction DNA as compared to duplex and
single-stranded DNA [91]. Residues 340-554 of BRCA1
have been identified as the minimal DNA-binding
region [93]. The highest affinity among the different
DNA targets which mimic damaged DNA (four-way
junction DNA, DNA mismatches, DNA bulges and lin-
ear DNA) was for DNA four-way junctions. To this end,
a 20-fold excess of linear DNA was unable to compete
off any of the BRCA1 230-534 bound to DNA molecules
mimicking damaged DNA [49]. Furthermore, the loss of
the BRCA1 gene prevents cell survival after exposure to
DNA cross-linkers such as mitomycin C [94]. These
results speak to the importance of BRCA1’s ability to
recognize cruciform structures.
HMGB family The high mobility-group (HMG) pro-
teins are a family of abundant and ubiquitous non-his-
tone proteins that are known to bind to eukaryotic
chromatin. The three HMG protein families comprise
the (a) HMGA proteins (formerly HMGI/Y) containing
A/T-hook DNA-binding motifs, (b) HMGB proteins
(formerly HMG1/2) containing HMG-box domain(s),
and (c) HMGN proteins (formerly HMG14/17) contain-
ing a nucleosome-binding domain [95].
HMGB proteins bind DNA in a sequence independent
manner and are known to bind to certain DNA struc-
tures (four-way junctions, DNA minicircles, cis-plati-
nated DNA, etc.) with high affinity as compared to
linear DNA [96,97]. The chromatin architectural protein
HMGB1 can bind with extremely high affinity to DNA
structures that form DNA loops [72], while other stu-
dies have shown that the HMG box of different proteins
can induce DNA bending [98-100]. The HMG box is an
80 amino acid domain found in a variety of eukaryotic
chromosomal proteins and transcription factors. HMG
box binding to DNA is associated with distortions in
DNA structure. Members of the HMG protein family
are involved in transcription [101-103] and DNA repair
[57,104,105]. The HMG protein T160 was found to be
co-localized with DNA replication foci [106]. The fact
that all HMG box domains bind to four-way DNA junc-
tions suggests that a common feature in the binding tar-
gets of this protein family must exist. Single HMG box
domains interact exclusively with the open square form
of the junction, and conditions that stabilize the stacked
× structure conformation significantly weaken the HMG
box DNA interaction [107]. Binding of the isolated A
domain of HMGB1 protein to four-way junction DNA
substrates is abolished by mutation of both Lys2 and
Lys11 together to alanine, indicating that these residues
play an important role in DNA binding [108].
Proteins involved in replication
Transient transitions from B-DNA to cruciform struc-
tures are correlated with DNA replication and transcrip-
tion [109]. It has been shown that cruciforms serve as
recognition signals at or near eukaryotic origins of DNA
replication [110-112]. There are a large number of pro-
teins involved in replication which bind to cruciform
structures (see Table 1). We focus here primarily on the
14-3-3 protein family and MLL and WRN proteins. We
will comment briefly on other systems of interest.
S16 is a structure-specific DNA-binding protein dis-
playing preferential binding for cruciform DNA struc-
tures [113]. The AF10 protein binds cruciform DNA via
a specific interaction with an AT-hook motif and is
localized to the nucleus by a defined bipartite nuclear
localization signal in the N-terminal region [114]. The
structural maintenance of chromosomes (SMC) protein
family, with members from lower and higher eukaryotes,
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and two SMC-like protein subfamilies (SMC5 and
SMC6) [115-117]. Members of this family are implicated
in a large range of activities that modulate chromosome
structure and organization. Smc1 and smc2 proteins
have a high affinity for cruciform DNA molecules and
for AT-rich DNA fragments including fragments from
the scaffold-associated regions [118]. The baculovirus
very late expression factor 1 (VLF-1), a member of the
integrase protein family, does not bind to single and
double strand structures, but it does bind (listed with
increasing affinity) to Y-forks, three-way junctions and
cruciform structures. This protein is involved in the
processing of branched DNA molecules at the late
stages of viral genome replication [119].
14-3-3 The 14-3-3 protein family consists of a highly
conserved and widely distributed group of dimeric pro-
teins which occur as multiple isoforms in eukaryotes
[120]. There are at least seven distinct 14-3-3 genes in
vertebrates, giving rise to nine isoforms (a, b, g, δ, ε, ζ,
h, s and τ) and at least another 20 have been identified
in yeast, plants, amphibians and invertebrates [110]. A
striking feature of the 14-3-3 proteins is their ability to
bind a multitude of functionally diverse signaling pro-
teins, including kinases, phosphatases, and transmem-
brane receptors. This plethora of proteins allows 14-3-3s
to modulate a wide variety of vital regulatory processes,
including mitogenic signal transduction, apoptosis and
cell cycle regulation [121]. The 14-3-3 proteins are
found mainly within the nucleus and are involved in
eukaryotic DNA replication via binding to the cruciform
DNA that forms transiently at replication origins at the
onset of the S phase [122].
14-3-3 cruciform binding activity was first observed in
proteins purified from sheep’s brain. More recently,
immunofluorescence analyses showed that 14-3-3 iso-
forms with cruciform-binding activity are present in
HeLa cells [123]. The direct interaction with cruciform
DNA was confirmed with 14-3-3 isoforms b, g, s, ε, and
ζ [34]. 14-3-3 analogs with cruciform-specific binding
are also found in yeast (Bmh1 and Bmh2) and plants
(GF14) [35].
The prevalence of the 14-3-3 family proteins in all
eukaryotes combined with a high degree of sequence
conservation between species is indicative of their
importance. Genetic studies have shown that knocking
out the yeasts homologs of the 14-3-3 proteins is lethal
[124]. Moreover, 14-3-3 proteins are involved in interac-
tions with numerous transcription factors and it has
been reported that several of the 14-3-3 proteins func-
tions are associated with its cruciform binding
properties.
Mixed lineage leukemia (MLL) protein The MLL gene
encodes a putative transcription factor with regions of
homology to several other proteins including the zinc
fingers and the so-called “AT-hook” DNA-binding motif
of high mobility group proteins [125]. The 11q23 chro-
mosomal translocation, found in both acute lymphoid
and myeloid leukemias, results in disruption of the MLL
gene. Leukemogenesis is often correlated with alterna-
tions in chromatin structure brought about by either a
gain or loss in function of the regulatory factors due to
their being disrupted by chromosomal translocations.
The MLL gene, a target of such translocation events,
forms a chimeric fusion product with a variety of part-
ner genes [126].
The MLL AT-hook domain binds cruciform DNA,
recognizing the structure rather than the sequence of
the target DNA. This interaction can be antagonized
both by Hoechst 33258 dye and distamycin. In a nitro-
cellulose protein-DNA binding assay, the MLL AT-hook
domain was shown to bind to AT-rich SARs, but not to
non-SAR DNA fragments [125]. MLL appears to be
involved in chromatin-mediated gene regulation. In
translocations involving MLL, the loss of the activation
domain combined with the retention of a repression
domain alters the expression of downstream target
genes, thus suggesting a potential mechanism of action
for MLL in leukemia [126]. AF10 translocations to the
vicinity of genes other than MLL also result in myeloid
leukemia. A biochemical analysis of the MLL partner
gene AF10 showed that its AT-hook motif is able to
bind to cruciform DNA, but not to double-stranded
DNA, and that it forms a homo-tetramer in vitro [114].
WRN T h eW e r n e rs y n d r o m ep r o t e i nb e l o n g st ot h e
RecQ family of evolutionary conserved 3’ ® 5’ DNA
helicases [127]. WRN encodes a single polypeptide of
162 kDa that contains 1432 amino acids. Prokaryotes
and lower eukaryotes generally have one RecQ member
while higher eukaryotes possess multiple members and
five homologs have been identified in human cells. All
RecQ members share a conserved helicase core with
one or two additional C-terminal domains, the RQC
(RecQ C-terminal) and HRDC (helicase and RNaseD C-
terminal) domains. These domains bind both to proteins
and DNA. Eukaryotic RecQ helicases have N- and C-
terminal extensions that are involved in protein-protein
interactions and have been postulated to lend unique
functional characteristics to these proteins [55,128].
WRN has been shown to bind at replication fork junc-
tions and to Holliday junction structures. Binding to
junction DNA is highly specific because little or no
WRN binding is visualized at other sites along these
substrates [129]. Upon binding to DNA, WRN assem-
bles into a large complex composed of four monomers.
Cruciform binding proteins and disease
The recognition of DNA junctions and cruciform struc-
t u r e si sc r i t i c a lf o rg e n o mic stability and for the
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Page 10 of 16regulation of basic cellular processes. The resolution of
Holliday junctions and long cruciforms is necessary for
genomic stability where the dysregulation of these pro-
teins can lead to DNA translocations, deletions, loss of
genomics stability and carcinogenesis. The large num-
bers of proteins which bind to these DNA structures
work together to keep the genome intact. We believe
that the formation of cruciform structures serves as a
marker for the proper timing and initiation of some
very basic biological processes. The mutations and epi-
genetic modifications that alter the propensity for cruci-
form formation can have drastic consequences for
cellular processes. Thus, it is unsurprising that the dys-
regulation of cruciform binding proteins is often asso-
ciated with the pathology of disease.
As stated above, the cruciform binding proteins
including p53, BRCA1, WRN and the proto-oncogenes
DEK, MLL and HMG are also associated with cancer
development and/or progression. Some of these proteins
play such important roles that their mutation and/or
inactivation result in severe genomic instability and
sometimes lethality. For example, Brca1 -/- mouse
embryonic stem cells show spontaneous chromosome
breakage, profound genomic instability and hypersensi-
tivity to a variety of damaging agents (e.g. g radiation)
all of which suggests a defect in DNA repair. The con-
nection between the BRCA1 mutation and breast cancer
is well known. P53’s transcriptional regulation is fine-
tuned by its timely binding to promoter elements. The
formation of a cruciform structure in p53 recognition
elements may be an important determinant of p53 tran-
scription activity.
T h ed H M G I ( Y )f a m i l yo f“high mobility group” non-
histone proteins comprises architectural transcription
factors whose over expression is highly correlated with
carcinogenesis, increased malignancy and metastatic
potential of tumors in vivo [95]. 14-3-3 proteins are
related to several diseases, including cancer, Alzehei-
mer’s disease, the neurological Miller Dieker and Spino-
cerebellar ataxia type 1 diseases, and spongiform
encephalopathy. The deletion of 14-3-3s in human col-
orectal cancer cells leads to the loss of the DNA damage
checkpoint control [130]. The human DEK protein was
discovered as a fusion with a nuclear pore protein in a
subset of patients with acute myeloid leukemia. It was
also identified as an autoantigen in a relatively high per-
centage of patients with autoimmune diseases. In addi-
tion, DEK mRNA levels are higher in transcriptionally
active and proliferating cells than in resting cells, and
elevated mRNA levels are found in several transformed
and cancer cells [6,7]. Werner syndrome is an autosomal
recessive disorder characterized by features of premature
aging and a high incidence of uncommon cancers [127].
The Werner syndrome protein (WRN) plays central
roles in maintaining the genomic stability of organisms
[131]. Individuals harboring mutations in WRN have a
rare, autosomal recessive genetic disorder manifested by
early onset of symptoms characteristic of aged
individuals.
Conclusions
Cruciform structures are fundamentally important for a
wide range of biological processes, including DNA tran-
scription, replication, recombination, control of gene
expression and genome organization. The putative
mechanistic roles of cruciform binding proteins in tran-
scription, DNA replication, and DNA repair are shown
in Figure 5. Alternative DNA structures, including cruci-
forms, are often formed at sites of negatively supercoiled
DNA by perfect or imperfect inverted repeats of 6 or
more nucleotides. Longer DNA palindromes present a
threat to genomic stability as they are recognized by
junction-resolving enzymes. Shorter palindromic
sequences are essential for basic processes like DNA
replication and transcription. The presence of cruciform
structures may also play an important role in epige-
netics, such that cruciform structures are protected
from DNA methylation. For example, the Dam methy-
lase is not able to modify its GATC target site when it
occurs in a cruciform or hairpin conformation. The cen-
ter of a long perfect palindrome located in bacterioph-
age lambda has also been shown to be methylation-
resistant in vivo [40]. Moreover, the centers of long
palindromes are hypo-methylated as compared to identi-
cal sequences in non-palindromic conformations [40].
To this end, transient cruciforms can directly influence
DNA methylation and therefore provide another layer
for regulation of the DNA code. Proteins that bind to
cruciforms can be divided into several categories. In
addition to a well defined group of junction-resolving
enzymes, we have classified cruciform binding proteins
into groups involved in transcription and DNA repair
(PARP, BRCA1, p53, 14-3-3), chromatin-associated pro-
teins (DEK, BRCA1, HMG protein family, topoisome-
rases), and proteins involved in replication (MLL, WRN,
14-3-3, helicases) (see Table 1). Within these groups are
proteins indispensable for cell viability, as well as tumor
suppressors, proto-oncogenes and DNA remodeling pro-
teins. Similarly, triplet repeat expansion, a phenomenon
important in several genetic diseases, including Frie-
dreich’s ataxia, cardiomyopathy, myotonic dystrophy
type I and other neurological disorders, can change the
spectrum of cruciform binding proteins. Lastly, single
nucleotide polymorphisms and/or insertion/deletion
mutations at inverted repeats located in promoter sites
can also influence cruciform formation, which might be
manifested through altered gene regulation. A deeper
understanding of the processes related to the formation
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Page 11 of 16Figure 5 Scheme of the putative mechanistic roles of cruciform binding proteins in transcription, DNA replication, and DNA repair.A )
A model for the structure-specific binding of transcription factors to a cognate palindrome-type cruciform implicated in transcription. The
equilibrium between classic B-DNA and the higher order cruciform favors duplex DNA, but, when cruciform binding proteins are present, they
either preferentially bind to and stabilize the cruciform or bind to the classic form and convert it to the cruciform. This interaction results in both
an initial melting of the DNA region covered by transcription factor and an extension of the melt region in both directions. The melting region
continues to extend in response to the needs of the active transcription machinery. B) A model for the initiation of replication enhanced by
extrusion to a cruciform structure. Dimeric cruciform binding proteins interact with and stabilize the cruciform structure. The replisome is
assembled concomitantly and is assumed to include polymerases, single-strand binding proteins and helicases. C) Model for the influence of
cruciform binding proteins on DNA structure in DNA damage regulation. Naked cruciforms are sensitive to DNA damage and are covered by
proteins in order to protect these sequences from being cleaved. In these cases, a deficiency in cruciform binding proteins can lead to DNA
breaks. Here, cruciform-DNA complexes can also serve as scaffolds to recruit the DNA damage machinery.
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Page 12 of 16and function of alternative DNA structures will be an
important component to consider in the post-genomic
era.
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